Teacher Retirement System Of Texas Chemo Centryx, Inc. Transaction History

Teacher Retirement System Of Texas

$20.2 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 03, 2022	BUY	$22.17 - $51.8 $210,659 - $492,203	9,502 Added 103.95%	18,643 $963,000
Q2 2022 Aug 09, 2022	SELL	$15.36 - $27.51 $13,178 - $23,603	-858 Reduced 8.58%	9,141 $227,000
Q1 2022 May 09, 2022	BUY	$22.22 - $39.12 $18,687 - $32,899	841 Added 9.18%	9,999 $251,000
Q4 2021 Feb 10, 2022	BUY	$18.38 - $40.5 $168,324 - $370,899	9,158 New	9,158 $333,000
Q2 2021 Aug 05, 2021	SELL	$9.59 - $50.88 $51,584 - $273,683	-5,379 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$49.53 - $68.4 $48,985 - $67,647	989 Added 22.53%	5,379 $276,000
Q4 2020 Feb 11, 2021	BUY	$47.25 - $65.16 $207,427 - $286,052	4,390 New	4,390 $272,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.